Chuzi Mo is a researcher at the Faculty of Dentistry at the University of Hong Kong, focusing on the tumor microenvironment, immune checkpoint inhibitors, and mechanisms of therapeutic resistance. Her work investigates how the interplay between tumor cells and immune components influences treatment outcomes, particularly in the context of immunotherapy. By integrating molecular, cellular, and translational approaches, Chuzi aims to elucidate resistance pathways and identify novel strategies to enhance the efficacy and durability of immune-based treatments. Her research aspires to advance the understanding of cancer biology and contribute to the development of precision therapies that can be effectively translated into clinical practice.